Spravato
Spravato for Treatment-Resistant Depression (TRD)
Is your depression not responding to medication and therapy? Consider Spravato at Conventions Psychiatry and Counseling in Naperville, IL. Spravato is an FDA-approved nasal spray for treatment-resistant depression, used in conjunction with your current oral antidepressants. Proven effective for adults with Major Depressive Disorder (MDD) who have not seen improvement with at least two medications, Spravato is administered twice weekly.
Schedule a consultation with Michelle dela Peña to discuss expectations, benefits, and risks, and explore whether Spravato treatment is right for you.
Spravato Treatments In Naperville
While Spravato is self-administered, patients are required to come in to Conventions Psychiatry twice weekly to administer usage under staff supervision. Patients must be also be monitored in office for two hours after each administration. This is to ensure safety and allow our certified medical professionals to assist with any side effects that may occur.
Side Effects
- Sedation
- Dissociation
- Nausea
- Increased blood pressure
Patients must be driven home after each treatment.
Spravato is not to be used in those with a history of bleeding in the brain, aneurysm, arteriovenous malformation, substance abuse, or pregnancy.